Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Metabolism & Endocrine
Filter     Order     Display # 
Date Item Title
07 Jan 2008 Sirtris Announces Positive Results with Proprietary Version of Resveratrol, SRT501, in a Phase 1b Type 2 Diabetes Clinical Study
04 Jan 2008 Metabasis Announces Preliminary Safety and Efficacy Results from an Ongoing Phase 1b Clinical Trial for MB07811
03 Jan 2008 Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
02 Jan 2008 Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
24 Dec 2007 Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
20 Dec 2007 Actelion enters Phase III with novel orexin receptor
19 Dec 2007 Galapagos announces osteoporosis collaboration with Lilly
19 Dec 2007 Biovitrum has Successfully Completed the First Phase I Trial of its 5-HT6 Receptor Antagonist (BVT.74316)
19 Dec 2007 Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
18 Dec 2007 Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
18 Dec 2007 AtheroGenics Completes Enrollment in ANDES Phase III Clinical Trial of AGI-1067
17 Dec 2007 Galvus(R), a new oral treatment for type 2 diabetes, receives positive opinion following changes to European prescribing information
14 Dec 2007 Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
14 Dec 2007 Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
14 Dec 2007 Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
13 Dec 2007 Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
13 Dec 2007 Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
13 Dec 2007 Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
13 Dec 2007 Liponex Updates CRD5 Status and Corporate Strategy
13 Dec 2007 BioMarin Announces FDA Approval for Kuvan
13 Dec 2007 FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-prescription MEVACOR(R)(lovastatin) 20 mg
12 Dec 2007 Ceregene Presents Long-Term Follow-Up from Phase 1 Trial of CERE-120 in Parkinson's Disease
11 Dec 2007 Final phase 3 study confirms very favourable effect of liraglutide on blood glucose control and body weight
07 Dec 2007 Submission of Marketing Authorisation Application for Dapoxetine in Europe
07 Dec 2007 Access Pharmaceuticals Demonstrates Ability To Significantly Reduce Glucose Levels in Pre-clinical Testing of
04 Dec 2007 Karo Bio Has Initiated Clinical Trials With KB3305
03 Dec 2007 Clal Biotechnology Industries and Teva Pharmaceuticals Solidify their Collaboration for Final Stage Development of Type 1 Diabetes Drug
29 Nov 2007 Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
29 Nov 2007 Eisai Submits NDA Application of KES524 for Obesity Management in Japan
29 Nov 2007 Amarin Commences First Clinical Trial in Cardiovascular Program
28 Nov 2007 Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
28 Nov 2007 Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
28 Nov 2007 Zosano Pharma, Inc. Closes Enrollment in Phase 2 Trial
28 Nov 2007 Valeant Pharmaceuticals Starts Phase 2 Retigabine Study for Treatment of Postherpetic Neuralgia
27 Nov 2007 Eurand Completes Bioavailability Study of Zentase(TM)
27 Nov 2007 BioMarin Files Investigational New Drug Application for PEG-PAL for the Treatment of PKU
22 Nov 2007 Diamyd Executes Agreement With US National Institutes of Health For a Type 1 Diabetes Trial With The Experimental Diamyd(R) Diabetes Vaccine
20 Nov 2007 New phase 2 study shows that liraglutide leads to significant weight loss in obese people
16 Nov 2007 VIVUS Initiates Second Qnexa Pivotal Phase 3 Trial in Obese Patients
15 Nov 2007 FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
15 Nov 2007 Oramed Pharmaceuticals Successfully Completes Animal Studies for Phase 1B Clinical Trials Of Its Oral Insulin Capsule
15 Nov 2007 Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
14 Nov 2007 Karo Bio Initiates Phase IIb Clinical Study With KB2115
14 Nov 2007 GlaxoSmithKline revises US labeling for Avandia
13 Nov 2007 Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
12 Nov 2007 FDA Accepts Akesis Pharmaceuticals’ AKP-020 IND Application for a Phase IIa Study in the Treatment of Type 2 Diabetes
11 Nov 2007 AtheroGenics Modifies ANDES Clinical Trial Discontinuing Highest Dose of AGI-1067
09 Nov 2007 CRESTOR(R) Now Indicated To Slow The Progression Of Atherosclerosis In Patients With Elevated Cholesterol
09 Nov 2007 VIVUS Initiates Pivotal Phase 3 Trial in Obese Patients and Announces Qnexa Dose
08 Nov 2007 Merck Submits European Marketing Authorization Application for Sapropterin as a Treatment for Hyperphenylalaninemia
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 301 - 350 of 1042

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics